Header Logo

Connection

Yuki Kageyama to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Carcinoma, Transitional Cell.
Yuki Kageyama
Connection Strength
1.594
Carcinoma, Transitional Cell
  1. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Res. 2022 Feb; 42(2):1131-1136.
    View in: PubMed
    Score: 0.694
  2. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol. 2000 Dec; 30(12):553-6.
    View in: PubMed
    Score: 0.160
  3. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 2020 11; 9(22):8355-8363.
    View in: PubMed
    Score: 0.157
  4. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract. Jpn J Clin Oncol. 1995 Oct; 25(5):173-8.
    View in: PubMed
    Score: 0.112
  5. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004 Mar; 171(3):1080-4.
    View in: PubMed
    Score: 0.050
  6. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res. 2003 Jul-Aug; 23(4):3441-6.
    View in: PubMed
    Score: 0.048
  7. [Fibroepithelial polyp of the anterior urethra, found during post-operative follow-up of ureteral cancer]. Hinyokika Kiyo. 2003 Jan; 49(1):29-31.
    View in: PubMed
    Score: 0.046
  8. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells. Anticancer Res. 2002 Sep-Oct; 22(5):2607-12.
    View in: PubMed
    Score: 0.045
  9. Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer. Urology. 2002 May; 59(5):774-8.
    View in: PubMed
    Score: 0.044
  10. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999 Oct; 36(4):309-13.
    View in: PubMed
    Score: 0.037
  11. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1999 Jul; 90(7):753-7.
    View in: PubMed
    Score: 0.036
  12. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33(5):464-8.
    View in: PubMed
    Score: 0.033
  13. Significant telomere reduction in human superficial transitional cell carcinoma. Br J Urol. 1996 Nov; 78(5):704-8.
    View in: PubMed
    Score: 0.030
  14. [En bloc cystourethrectomy with preservation of potency]. Nihon Hinyokika Gakkai Zasshi. 1996 Mar; 87(3):676-81.
    View in: PubMed
    Score: 0.029
  15. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines]. Hinyokika Kiyo. 1990 Aug; 36(8):903-6; Discussion 906-7.
    View in: PubMed
    Score: 0.020
  16. [A study of intercellular communication of human transitional cell carcinoma cell lines]. Nihon Hinyokika Gakkai Zasshi. 1989 Jul; 80(7):988-94.
    View in: PubMed
    Score: 0.018
  17. [The clinical study of 23 cases in patients with bladder cancer over 85 years old]. Hinyokika Kiyo. 1989 Jul; 35(7):1141-4.
    View in: PubMed
    Score: 0.018
  18. [Urinary bladder tumor manifesting multiple bone metastases similar to prostatic carcinoma--a case report]. Gan No Rinsho. 1988 Jan; 34(1):111-4.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.